Key facts
- SafeHeal’s last known valuation is $53.5M (Feb 2022).
- It has raised $121.3M; the latest was Later Stage VC ($52.6M) in Sep 2025.
- Notable investors include Bpifrance, MedTech Innovator, Sofinnova Partners, Johnson & Johnson JJDC, Asabys Partners — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for SafeHeal
- ·The full record, as it builds
Funding rounds
No funding rounds for SafeHeal are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SafeHeal
Manufacturer of a flexible bypass sheath intended to improve the postoperative lives of patients being treated for colorectal cancer. The company's sheath uses a vacuum-based mechanism that remains in place until the body's natural healing and tissue repair processes are complete, enabling surgeons to have a device designed to protect gastrointestinal anastomosis and avoid Ostomy creation.
- Sector
- Healthcare
- HQ
- Roubaix, France
- Founded
- 2015
- Employees
- 22
- Website
- safeheal.com/
- Ownership
- Privately Held (backing)
SafeHeal doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SafeHeal shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SafeHeal in its N-PORT filings yet. We sweep new filings monthly.